1. Home
  2. GAIA vs IFRX Comparison

GAIA vs IFRX Comparison

Compare GAIA & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAIA
  • IFRX
  • Stock Information
  • Founded
  • GAIA 1988
  • IFRX 2007
  • Country
  • GAIA United States
  • IFRX Germany
  • Employees
  • GAIA N/A
  • IFRX N/A
  • Industry
  • GAIA Movies/Entertainment
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAIA Consumer Discretionary
  • IFRX Health Care
  • Exchange
  • GAIA Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • GAIA 116.3M
  • IFRX 117.8M
  • IPO Year
  • GAIA 1999
  • IFRX 2017
  • Fundamental
  • Price
  • GAIA $4.15
  • IFRX $1.15
  • Analyst Decision
  • GAIA Strong Buy
  • IFRX Strong Buy
  • Analyst Count
  • GAIA 2
  • IFRX 1
  • Target Price
  • GAIA $8.00
  • IFRX $8.00
  • AVG Volume (30 Days)
  • GAIA 36.9K
  • IFRX 623.9K
  • Earning Date
  • GAIA 03-10-2025
  • IFRX 05-07-2025
  • Dividend Yield
  • GAIA N/A
  • IFRX N/A
  • EPS Growth
  • GAIA N/A
  • IFRX N/A
  • EPS
  • GAIA N/A
  • IFRX N/A
  • Revenue
  • GAIA $90,363,000.00
  • IFRX $187,930.00
  • Revenue This Year
  • GAIA $15.76
  • IFRX $396.02
  • Revenue Next Year
  • GAIA $15.91
  • IFRX $155.22
  • P/E Ratio
  • GAIA N/A
  • IFRX N/A
  • Revenue Growth
  • GAIA 12.36
  • IFRX 177.12
  • 52 Week Low
  • GAIA $2.85
  • IFRX $1.14
  • 52 Week High
  • GAIA $6.53
  • IFRX $2.82
  • Technical
  • Relative Strength Index (RSI)
  • GAIA 35.32
  • IFRX 24.46
  • Support Level
  • GAIA $3.80
  • IFRX $1.76
  • Resistance Level
  • GAIA $4.36
  • IFRX $1.34
  • Average True Range (ATR)
  • GAIA 0.27
  • IFRX 0.14
  • MACD
  • GAIA -0.03
  • IFRX -0.01
  • Stochastic Oscillator
  • GAIA 35.00
  • IFRX 1.39

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an international presence.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: